SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-17-003488
Filing Date
2017-01-30
Accepted
2017-01-30 16:55:33
Documents
1
Period of Report
2017-01-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 4160
  Complete submission text file 0001140361-17-003488.txt   5677
Mailing Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804
Business Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804 5109706000
SANGAMO THERAPEUTICS, INC (Issuer) CIK: 0001001233 (see all company filings)

IRS No.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 501 CANAL BLVD. POINT RICHMOND TECH CENTER RICHMOND CA 94804
Business Address
Herberts Curt A. III (Reporting) CIK: 0001691262 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-30171 | Film No.: 17558155